#coag
Latest news and interesting information about coag.
Goldman Sachs Initiates Hemab Buy
Goldman Sachs initiates Hemab Therapeutics with buy rating. Sutacimig and HMB-002 target rare bleeding disorders.
Adecoagro Q1 2026: EPS Miss, Revenue Beat
Adecoagro Q1 2026 results: EPS misses forecasts but revenue beats. Adjusted EBITDA doubles to $86M. Fertilizer segment leads growth.
...

